Mitochondrial dysfunction promotes cell migration via reactive oxygen species-enhanced β5-integrin expression in human gastric cancer SC-M1 cells.

[1]  C. Chi,et al.  Somatic mutations of mitochondrial DNA in aging and cancer progression , 2010, Ageing Research Reviews.

[2]  Andrei V Bakin,et al.  Role of β5-integrin in epithelial-mesenchymal transition in response to TGF-β , 2010, Cell cycle.

[3]  G. Pani,et al.  Metastasis: cancer cell’s escape from oxidative stress , 2010, Cancer and Metastasis Reviews.

[4]  Kouji Katabami,et al.  Potentiation of cell invasion and matrix metalloproteinase production by α3β1 integrin-mediated adhesion of gastric carcinoma cells to laminin-5 , 2010, Clinical & Experimental Metastasis.

[5]  C. Chi,et al.  Somatic mutations in mitochondrial genome and their potential roles in the progression of human gastric cancer. , 2010, Biochimica et biophysica acta.

[6]  Jae Hoon Jeong,et al.  Mitochondrial dysfunction enhances the migration of vascular smooth muscles cells via suppression of Akt phosphorylation. , 2010, Biochimica et biophysica acta.

[7]  Sen Guo,et al.  Vascular endothelial growth factor (VEGF) enhances gastric carcinoma invasiveness via integrin alpha(v)beta6. , 2010, Cancer letters.

[8]  A. Vercesi,et al.  Mitochondria and reactive oxygen species. , 2009, Free radical biology & medicine.

[9]  S. Naylor,et al.  A heteroplasmic, not homoplasmic, mitochondrial DNA mutation promotes tumorigenesis via alteration in reactive oxygen species generation and apoptosis. , 2009, Human molecular genetics.

[10]  S. Hanks,et al.  Specific cross-talk between epidermal growth factor receptor and integrin alphavbeta5 promotes carcinoma cell invasion and metastasis. , 2009, Cancer research.

[11]  Yau-Huei Wei,et al.  Mitochondrial DNA Instability and Metabolic Shift in Human Cancers , 2009, International journal of molecular sciences.

[12]  Michael P. Murphy,et al.  How mitochondria produce reactive oxygen species , 2008, The Biochemical journal.

[13]  J. Hayashi,et al.  ROS-Generating Mitochondrial DNA Mutations Can Regulate Tumor Cell Metastasis , 2008, Science.

[14]  Michael S Janes,et al.  The selective detection of mitochondrial superoxide by live cell imaging , 2008, Nature Protocols.

[15]  E. Pagnotta,et al.  Biochemical phenotypes associated with the mitochondrial ATP6 gene mutations at nt8993. , 2007, Biochimica et biophysica acta.

[16]  Wen-Sheng Wu.  The signaling mechanism of ROS in tumor progression , 2007, Cancer and Metastasis Reviews.

[17]  E. Danen,et al.  Integrins: Signaling, disease, and therapy , 2007, International journal of radiation biology.

[18]  Marty C. Brandon,et al.  Mitochondrial mutations in cancer , 2006, Oncogene.

[19]  A. Chatterjee,et al.  Mitochondrial DNA mutations in human cancer , 2006, Oncogene.

[20]  S. Rhee,et al.  H2O2, a Necessary Evil for Cell Signaling , 2006, Science.

[21]  E. Bonora,et al.  Defective oxidative phosphorylation in thyroid oncocytic carcinoma is associated with pathogenic mitochondrial DNA mutations affecting complexes I and III. , 2006, Cancer research.

[22]  C. Chi,et al.  PTPN3 and PTPN4 tyrosine phosphatase expression in human gastric adenocarcinoma. , 2006, Anticancer research.

[23]  D. Wallace.  A Mitochondrial Paradigm of Metabolic and Degenerative Diseases, Aging, and Cancer: A Dawn for Evolutionary Medicine , 2005, Annual review of genetics.

[24]  C. Chi,et al.  Mitochondrial DNA mutations and mitochondrial DNA depletion in breast cancer , 2005, Genes, chromosomes & cancer.

[25]  C. Chi,et al.  Mitochondrial DNA mutations and mitochondrial DNA depletion in gastric cancer , 2005, Genes, chromosomes & cancer.

[26]  P. Beaune,et al.  Clinical value of mitochondrial mutations in colorectal cancer. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[27]  S. Ohta,et al.  Positive contribution of pathogenic mutations in the mitochondrial genome to the promotion of cancer by prevention from apoptosis. , 2005, Cancer research.

[28]  A. Tamori,et al.  Correlation between clinical characteristics and mitochondrial D-loop DNA mutations in hepatocellular carcinoma , 2004, Journal of Gastroenterology.

[29]  V. Carelli,et al.  Bioenergetics of mitochondrial diseases associated with mtDNA mutations. , 2004, Biochimica et biophysica acta.

[30]  G. Poli,et al.  Oxidative stress and cell signalling. , 2004, Current medicinal chemistry.

[31]  Marta Martínez,et al.  Alteration of the bioenergetic phenotype of mitochondria is a hallmark of breast, gastric, lung and oesophageal cancer. , 2004, The Biochemical journal.

[32]  Nastaran Zahir,et al.  Autocrine laminin-5 ligates α6β4 integrin and activates RAC and NFκB to mediate anchorage-independent survival of mammary tumors , 2003, The Journal of cell biology.

[33]  Mitsuhiro Osame,et al.  Mitochondrial DNA mutation correlates with stage progression and prognosis in non‐small cell lung cancer , 2003, Human mutation.

[34]  Kathy Pfeiffer,et al.  Low mitochondrial respiratory chain content correlates with tumor aggressiveness in renal cell carcinoma. , 2002, Carcinogenesis.

[35]  R. Seruca,et al.  Microsatellite instability, mitochondrial DNA large deletions, and mitochondrial DNA mutations in gastric carcinoma , 2001, Genes, chromosomes & cancer.

[36]  Arnoud Sonnenberg,et al.  Function and interactions of integrins , 2001, Cell and Tissue Research.

[37]  N. B. Atkin.  Microsatellite instability , 2001, Cytogenetic and Genome Research.

[38]  Semi Kim,et al.  Regulation of Integrin αvβ3-mediated Endothelial Cell Migration and Angiogenesis by Integrin α5β1 and Protein Kinase A* , 2000, The Journal of Biological Chemistry.

[39]  H. C. Lee,et al.  Increase of mitochondria and mitochondrial DNA in response to oxidative stress in human cells. , 2000, The Biochemical journal.

[40]  Semi Kim,et al.  Regulation of Angiogenesis in Vivo by Ligation of Integrin α5β1 with the Central Cell-Binding Domain of Fibronectin , 2000 .

[41]  P. Schwartzberg,et al.  Selective requirement for Src kinases during VEGF-induced angiogenesis and vascular permeability. , 1999, Molecular cell.

[42]  Leslie M Shaw,et al.  Activation of Phosphoinositide 3-OH Kinase by the α6β4 Integrin Promotes Carcinoma Invasion , 1997, Cell.

[43]  W. Stetler-Stevenson,et al.  Localization of Matrix Metalloproteinase MMP-2 to the Surface of Invasive Cells by Interaction with Integrin αvβ3 , 1996, Cell.

[44]  D. Shibata,et al.  Somatic mitochondrial mutation in gastric cancer. , 1995, The American journal of pathology.

[45]  A. Ooi,et al.  Integrin distribution in gastric carcinoma: Association of β3 and β5 integrins with tumor invasiveness , 1995 .

[46]  V. Quaranta,et al.  A Monoclonal Antibody Inhibits Adhesion to Fibronectin and Vitronectin of a Colon Carcinoma Cell Line and Recognizes the Integrins αvβ3, αvβ5, and αvβ6 , 1994 .

[47]  C. Tzeng,et al.  Cytogenetic studies of gastric adenocarcinoma. , 1991, Cancer genetics and cytogenetics.

[48]  Nils Cordes,et al.  Signalling via integrins: implications for cell survival and anticancer strategies. , 2007, Biochimica et biophysica acta.